Literature DB >> 21678454

Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients.

Wolfgang Dichtl1, Thomas Wolber, Ursula Paoli, Simon Brüllmann, Markus Stühlinger, Thomas Berger, Karin Spuller, Alexander Strasak, Otmar Pachinger, Laurent M Haegeli, Firat Duru, Florian Hintringer.   

Abstract

BACKGROUND: Inappropriate implantable cardioverter defibrillator (ICD) shocks have been linked to a worse clinical outcome due to direct myocardial injury. HYPOTHESIS: The occurrence of ventricular tachyarrhythmia indicating progression of the underlying heart disease, but not the ICD shock itself, has prognostic impact in clinical routine.
METHODS: In a retrospective study, 1117 recipients of an ICD were analyzed with respect to appropriate and inappropriate therapies and survival.
RESULTS: During a mean follow-up of 2.92 years, appropriate therapy occurred in 27.7% and 54.0% of patients who had received an ICD for primary and secondary prevention of sudden cardiac death (SCD), respectively (P<0.0001). Inappropriate shock therapy occurred in 15.0% and 25.4% of patients who had received an ICD for primary and secondary prevention of SCD, respectively (P = 0.122). Appropriate ICD therapy had a strong impact on overall survival (P<0.0001), and this association was found both in primary (P<0.0001) and secondary (P = 0.002) prevention of SCD. Inappropriate ICD shocks had no impact on total mortality, neither in primary nor secondary prevention of SCD.
CONCLUSIONS: Inappropriate shocks do not affect survival, in strong contrast to appropriate ICD therapy. Our study does not support the hypothesis that shock therapy in itself worsens clinical outcome. However, it confirms that appropriate ICD therapy is a warning sign and should prompt physicians to consider additional treatment strategies.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21678454      PMCID: PMC6652665          DOI: 10.1002/clc.20910

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  14 in total

Review 1.  [What must intensive care physicians know about implantable cardioverter defibrillator?].

Authors:  E Gatterer
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-20       Impact factor: 0.840

2.  Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines.

Authors:  Yehoshua C Levine; Mark K Tuttle; Michael A Rosenberg; Randal Goldberg; Jason Matos; Michelle Samuel; Daniel B Kramer; Alfred E Buxton
Journal:  Am J Cardiol       Date:  2015-03-12       Impact factor: 2.778

3.  [Inappropriate ICD therapies: All problems solved with MADIT-RIT?].

Authors:  Christof Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-04-21

Review 4.  Recommendations for driving after implantable cardioverter defibrillator implantation and the use of a wearable cardioverter defibrillator : Different viewpoints around the world.

Authors:  Mona Cooper; Theresa Berent; Johann Auer; Robert Berent
Journal:  Wien Klin Wochenschr       Date:  2020-05-20       Impact factor: 1.704

5.  Increased Platelet-to-Lymphocyte Ratios and Low Relative Lymphocyte Counts Predict Appropriate Shocks in Heart Failure Patients with ICDs.

Authors:  Kevser Gülcihan Balci; Mustafa Mücahit Balci; Ugur Arslan; Burak Açar; Orhan Maden; Hatice Selcuk; Timur Selcuk
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

Review 6.  Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Authors:  Rebecca Persson; Amy Earley; Ann C Garlitski; Ethan M Balk; Katrin Uhlig
Journal:  J Interv Card Electrophysiol       Date:  2014-06-20       Impact factor: 1.900

7.  Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway.

Authors:  Eva R Serber; Joseph L Fava; Lillian M Christon; Alfred E Buxton; Jeffrey J Goldberger; Michael R Gold; James R Rodrigue; Michael B Frisch
Journal:  Pacing Clin Electrophysiol       Date:  2016-02-24       Impact factor: 1.976

8.  Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure.

Authors:  Thomas Bitter; Klaus-Jürgen Gutleben; Georg Nölker; Zisis Dimitriadis; Christian Prinz; Jürgen Vogt; Dieter Horstkotte; Olaf Oldenburg
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-07-29

9.  Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale.

Authors:  Milos Taborsky; Tomas Skala; Renata Aiglova; Marian Fedorco; Josef Kautzner; Tomas Jandik; Vlastimil Vancura; Ales Linhart; Martin Valek; Miloslav Novak; Petr Kala; Rostislav Polasek; Tomas Roubicek; Alexandr Schee; Gerhard Hindricks; Nikolaos Dagres; Robert Hatala; Jiri Jarkovsky
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-03-12       Impact factor: 1.245

10.  Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.

Authors:  Florian Streitner; Thomas Herrmann; Juergen Kuschyk; Siegfried Lang; Christina Doesch; Theano Papavassiliu; Ines Streitner; Christian Veltmann; Dariusch Haghi; Martin Borggrefe
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.